Polaris Management Co. Vii, L.l.c. - Net Worth and Insider Trading
Polaris Management Co. Vii, L.l.c. Net Worth
The estimated net worth of Polaris Management Co. Vii, L.l.c. is at least $310,983 dollars as of 2024-09-20. Polaris Management Co. Vii, L.l.c. is the 10% Owner of Syros Pharmaceuticals Inc and owns about 158,665 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $310,983. Details can be seen in Polaris Management Co. Vii, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Polaris Management Co. Vii, L.l.c. has not made any transactions after 2016-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Polaris Management Co. Vii, L.l.c.
Polaris Management Co. Vii, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Polaris Management Co. Vii, L.l.c. owns 3 companies in total, including Metacrine Inc (MTCR) , Syros Pharmaceuticals Inc (SYRS) , and SQZ Biotechnologies Co (SQZB) .
Insider Ownership Summary of Polaris Management Co. Vii, L.l.c.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MTCR | Metacrine Inc | 2020-09-15 | 10 percent owner |
| SYRS | Syros Pharmaceuticals Inc | 2016-07-06 | 10 percent owner |
| SQZB | SQZ Biotechnologies Co | 2020-10-29 | 10 percent owner |
Polaris Management Co. Vii, L.l.c. Latest Holdings Summary
Polaris Management Co. Vii, L.l.c. currently owns a total of 1 stock. Polaris Management Co. Vii, L.l.c. owns 158,665 shares of Syros Pharmaceuticals Inc (SYRS) as of July 6, 2016, with a value of $310,983.
Latest Holdings of Polaris Management Co. Vii, L.l.c.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2016-07-06 | 158,665 | 1.96 | 310,983 |
Holding Weightings of Polaris Management Co. Vii, L.l.c.
Polaris Management Co. Vii, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Polaris Management Co. Vii, L.l.c. has made a total of 0 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years. The most-recent trade in Syros Pharmaceuticals Inc is the acquisition of 40,000 shares on July 6, 2016, which cost Polaris Management Co. Vii, L.l.c. around $5 Million.
Insider Trading History of Polaris Management Co. Vii, L.l.c.
- 1
Polaris Management Co. Vii, L.l.c. Trading Performance
GuruFocus tracks the stock performance after each of Polaris Management Co. Vii, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Polaris Management Co. Vii, L.l.c. is -20.83%. GuruFocus also compares Polaris Management Co. Vii, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Polaris Management Co. Vii, L.l.c. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Polaris Management Co. Vii, L.l.c.'s insider trading performs compared to the benchmark.
Performance of Polaris Management Co. Vii, L.l.c.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -43.61 | | | | | |
| Relative Return to S&P 500(%) | -47.57 | | | | | |
Polaris Management Co. Vii, L.l.c. Ownership Network
Polaris Management Co. Vii, L.l.c. Owned Company Details
What does Metacrine Inc do?
Who are the key executives at Metacrine Inc?
Polaris Management Co. Vii, L.l.c. is the 10 percent owner of Metacrine Inc. Other key executives at Metacrine Inc include director & President & CEO Preston Klassen , Chief Business Officer Michael York , and 10 percent owner Braden Michael Leonard .
Metacrine Inc (MTCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Metacrine Inc Insider Transactions
Polaris Management Co. Vii, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Polaris Management Co. Vii, L.l.c.. You might contact Polaris Management Co. Vii, L.l.c. via mailing address: One Marina Park Drive, 10th Floor, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
